Search
Now showing items 1-6 of 6
Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
(2004)
Background: Impaired glucose tolerance is a risk factor for atherosclerosis in hemodialysis patients and renal transplant recipients. Methods: To check the relationship of impaired glucose tolerance with the other ...
Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste
(2006)
Objective: Gingival overgrowth is a complication of cyclosporine therapy following organ transplantation. Oral azithromycin is frequently used to treat this complication. This study examined the efficacy of local azithromycin, ...
The effect of red grape seed extract on serum paraoxonase activity in patients with mild to moderate hyperlipidemia [O efeito do extrato de semente de uva vermelha na atividade do soro paraoxonase em doentes com hiperlipidemia leve a moderada]
(2016)
CONTEXT AND OBJECTIVE: Red grape seed extract (RGSE) contains oligomeric proanthocyanidin complexes as a class of flavonoids. These compounds are potent antioxidants and exert many health-promoting effects. This study aimed ...
Findings of Doppler sonography do not correlate with serum lipoprotein and total homocysteine concentrations in renal transplant recipients
(2005)
Atherosclerosis may be evaluated by structural or functional changes of the main arteries. We sought to investigate the probable associations of static and dynamic arterial changes with lipoprotein (a) and homocysteine ...
Anatomical differences in the right and left renal arterial patterns
(2008)
The aim of this study was to determine the pattern and character of the renal arteries in patients referred for preoperative or diagnostic evaluation of the renal or abdominal arteries by multi-detector computed tomography ...
Apolipoprotein A polymorphysm predicts lipoprotein A concentration in renal transplant recipients
(2005)
Increased serum lipoprotein(a) is an independent risk factor for atherosclerosis in renal transplant recipients. Higher levels may be due to genetic factors, for example, apolipoprotein A isoforms and/or environmental ...